Kerala Ayurveda shareholders approve preferential issue of 6.55 lakh shares
- Kerala Ayurveda approved a preferential issue of 6,55,000 equity shares to Katra Holding Private Limited
- Special resolution passed to adjust existing unsecured loans against the new share issuance
- Audited standalone and consolidated financial statements for FY26 were adopted by shareholders
- Ramesh Vangal was reappointed as Director under an ordinary resolution
*this image is generated using AI for illustrative purposes only.
Kerala Ayurveda Limited held its 34th Annual General Meeting (AGM) on September 28, 2026, where shareholders approved a special resolution for the issuance of 6,55,000 equity shares on a preferential basis.
The meeting, conducted via video conferencing and other audio-visual means, saw the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. A key agenda item involved the partial adjustment of an existing unsecured loan from promoter group entity Katra Holding Private Limited against the new share issuance.
Key resolutions passed
The Board of Directors presented four items for shareholder approval, covering financial adoption, director reappointment, auditor remuneration, and capital restructuring. The results of the e-voting process are expected to be filed separately following the scrutinizer's report.
| Item | Particulars of resolution | Type |
|---|---|---|
| 1 | Adoption of audited standalone and consolidated financial statements for FY26 along with Auditors' and Board's Report | Ordinary |
| 2 | Reappointment of Ramesh Vangal as Director retiring by rotation | Ordinary |
| 3 | Ratification of remuneration payable to SLR & Associates, Kochi, as Cost Auditors | Ordinary |
| 4 | Issuance of 6,55,000 equity shares to Katra Holding Private Limited by adjusting unsecured loan | Special |
Meeting proceedings and attendance
The AGM commenced at 11:00 am and concluded at 12:35 pm. A total of 44 members, including authorized representatives, attended the virtual meeting. The requisite quorum was present, and the meeting was chaired by Ramesh Vangal, Chairman and Non-Executive Non-Independent Director.
Key management personnel in attendance included Vivek Sunder, Chief Executive Officer; George K T, Chief Financial Officer; and Binu Thomas, Company Secretary and Compliance Officer. Statutory Auditor Raphael Sharon from M/s. G Joseph & Associates and Secretarial Auditor C.S. Vincent P.D. from M/s. SVJS & Associates were also present.
Governance and compliance details
The Company Secretary informed members that the Annual Report for FY26, including the Notice of AGM, Auditor's Report, and Director's Report, was sent electronically and taken as read. Qualifications or observations made by the Statutory Auditors on the financial statements for the year ended March 31, 2026, were disclosed in the Board's Report alongside management responses.
Voting facilities were provided through remote e-voting from September 25, 2026, to September 27, 2026. Members present at the meeting who had not voted remotely were allowed to cast their votes during the session, with the voting line remaining open for an additional 15 minutes after the conclusion of proceedings.
Historical Stock Returns for Kerala Ayurveda
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -12.09% | -18.82% | -16.88% | -67.02% | 0.0% |
How will the dilution from issuing 6.55 lakh shares to Katra Holding Private Limited impact the current promoter holding percentage and minority shareholder rights?
What are the specific terms and interest rates of the unsecured loan from Katra Holding that is being converted into equity, and how does this affect the company's future debt servicing obligations?
Given the low attendance of 44 members, what measures is Kerala Ayurveda planning to implement to improve retail shareholder engagement and voting participation in future AGMs?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
